Vietnam Health Official Warns Drug Makers Against Price Increases
This article was originally published in PharmAsia News
Executive Summary
The chief inspector of Vietnam's Ministry of Health warned drug makers they will be fined or have their licenses revoked if they increase prices without authorization. The inspector said his office plans to keep an eye on hospitals to be sure the supplies they need are delivered and to ensure there is no withholding of drugs by manufacturers expecting the price to increase later. A ban on price increases expired June 30, but the ministry still must act on requests for higher prices submitted by drug firms. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.